CAMBRIDGE, Mass. , April 29, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the publication of a manuscript in Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research, which supports the rational molecular design of zidesamtinib, its novel and selective ROS1 inhibitor.

image for news Nuvalent Announces Publication in Molecular Cancer Therapeutics Reinforcing Rational Molecular Design of Zidesamtinib as a Novel ROS1-Selective Inhibitor

Meta releases standalone AI app, competing with ChatGPT — Positive

META   TechXplore — April 29, 2025

Social media behemoth Meta unveiled its first standalone AI assistant app on Tuesday as it tries to take on ChatGPT by giving users a direct path to its generative artificial intelligence models.

image for news Meta releases standalone AI app, competing with ChatGPT

Royal Caribbean Profit, Outlook Boosted by Higher Prices, Lower Costs — Positive

RCL   Investopedia — April 29, 2025

Royal Caribbean Group (RCL) reported quarterly profit exceeded forecasts and it boosted its outlook as it benefited from higher prices and lower costs.

image for news Royal Caribbean Profit, Outlook Boosted by Higher Prices, Lower Costs

Is NBIS Stock Worth Investing After a 24% Drop in the Past 3 Months? — Neutral

NBIS   Zacks Investment Research — April 29, 2025

Nebius benefits from expanding infrastructure offerings, but intense competition from tech behemoths and macroeconomic challenges remain concerns.

image for news Is NBIS Stock Worth Investing After a 24% Drop in the Past 3 Months?

Amazon probably won't be hiking prices too much if it's declining to show how much tariffs are impacting costs.

image for news Amazon says it won't show tariff impact on prices. That's actually a good sign.

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. (“Affirm” or the “Company”) (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Affirm Holdings, Inc. - AFRM

Hims & Hers stock pops on Novo Nordisk partnership — Positive

HIMS  NVO   Proactive Investors — April 29, 2025

Hims & Hers (NYSE:HIMS) shares surged after it announced a partnership with Novo Nordisk that will allow it to offer the drugmaker's weight loss product Wegovy through its telehealth platform. Investors welcomed the collaboration, which positions Hims & Hers to participate directly in the fast-growing market for GLP-1 weight-loss drugs.

image for news Hims & Hers stock pops on Novo Nordisk partnership

Uber: Compounder With AV Tailwind — Positive

UBER   Seeking Alpha — April 29, 2025

Uber's strong network effects and exclusive Waymo partnership position it as a key player in the autonomous vehicle market, enhancing its long-term growth prospects. Uber's core business segments, Mobility and Delivery, are performing well, showing significant year-over-year growth and strong operating leverage. At a 23x forward P/E, Uber is undervalued relative to its growth prospects, with a price target of $130, indicating a 70% upside.

image for news Uber: Compounder With AV Tailwind

Xylem Inc. (XYL) Q1 2025 Earnings Call Transcript — Neutral

XYL   Seeking Alpha — April 29, 2025

Xylem Inc. (NYSE:XYL ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Keith Buettner - Vice President, Investor Relations & Financial Planning & Analysis Matthew Pine - Chief Executive Officer Bill Grogan - Chief Financial Officer Conference Call Participants Deane Dray - RBC Capital Markets Mike Halloran - Baird Scott Davis - Melius Research Nathan Jones - Stifel Saree Boroditsky - Jefferies Bryan Blair - Oppenheimer Joe Giordano - TD Cowen Operator Good day, and welcome to Xylem's First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

image for news Xylem Inc. (XYL) Q1 2025 Earnings Call Transcript

JNPR Set to Report Q1 Results: What's in the Offing for the Stock? — Positive

JNPR   Zacks Investment Research — April 29, 2025

Juniper is expected to report top-line growth backed by healthy demand in the Cloud and Enterprise segments.

image for news JNPR Set to Report Q1 Results: What's in the Offing for the Stock?

Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales — Positive

PFE   Zacks Investment Research — April 29, 2025

PFE beats first-quarter estimates for earnings but misses the same for sales. It maintains 2025 guidance.

image for news Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales

President Donald Trump's wants to "drill, baby, drill" but his first 100 days in office have been rough for oilfield service firms. Baker Hughes and SLB see investment in drilling slowing this year as oil prices fall because of growing supply and concern over a recessionary slowdown.

image for news Oil companies that Trump wants to ‘drill, baby, drill' have taken a beating since he took office

S&P Global Inc. (SPGI) Q1 2025 Earnings Call Transcript — Neutral

SPGI   Seeking Alpha — April 29, 2025

S&P Global Inc. (NYSE:SPGI ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Mark Grant - Senior Vice President of Investor Relations Martina Cheung - President and Chief Executive Officer Eric Aboaf - Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Faiza Alwy - Deutsche Bank Surinder Thind - Jefferies Ashish Sabadra - RBC Capital Markets Andrew Steinerman - JPMorgan Scott Wurtzel - Wolfe Research Alex Kramm - UBS Manav Patnaik - Barclays George Tong - Goldman Sachs Tom Ross - William Blair Craig Huber - Huber Research Partners Owen Lau - …

image for news S&P Global Inc. (SPGI) Q1 2025 Earnings Call Transcript

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your AppLovin Corporation (NASDAQ:APP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applovin-corporation-lawsuit-submission-form?prid=146027&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds AppLovin Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025 - APP

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=146023&wire=1 or contact Joseph E. Levi, Esq.

image for news PPTA LAWSUIT ALERT: Levi & Korsinsky Notifies Perpetua Resources Corp. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your TFI International Inc. (NYSE:TFII) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/tfi-international-inc-lawsuit-submission-form?prid=146026&wire=1 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Reminds TFI International Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2025 - TFII

Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call Transcript — Neutral

REGN   Seeking Alpha — April 29, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Q1 2025 Earnings Conference Call April 29, 2025 8:30 AM ET Company Participants Ryan Crowe - SVP, IR Leonard Schleifer - Board Co-Chair, Co-Founder, President and CEO George Yancopoulos - Board Co-Chair, Co-Founder, President and Chief Scientific Officer Marion McCourt - EVP, Commercial Chris Fenimore - EVP and CFO Conference Call Participants Tyler Van Buren - TD Cowen Alexandria Hammond - Wolfe Research Chris Schott - JPMorgan Terence Flynn - Morgan Stanley Akash Tewari - Jefferies Carter Gould - Cantor William Pickering - Bernstein Evan Seigerman - BMO Capital Markets Salveen Richter - Goldman Sachs …

image for news Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call Transcript

NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=146022&wire=1 or contact Joseph E. Levi, Esq.

image for news Treace Medical Concepts, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - TMCI

NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / The Hertz Corporation recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals. This data breach has led to concerns over the security of sensitive personal and protected health information entrusted to Hertz.

image for news INVESTIGATION ALERT: Levi & Korsinsky, LLP Announces Investigation of the Hertz Corporation Data Breach

Levi & Korsinsky, LLP Investigates eBay Privacy Violation — Neutral

EBAY   Accesswire — April 29, 2025

NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Levi & Korsinsky, LLP is investigating potential claims on behalf of California residents, who are account holders with eBay and visited eBay's website at https://www.ebay.com. Levi &Korsinsky, LLP's investigation indicatesthat legally protected data may have been unlawfully intercepted during visits to eBay's website, particularly affectingusers who are California residents and areaccount holders with eBay.

image for news Levi & Korsinsky, LLP Investigates eBay Privacy Violation